Stability Biologics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Stability Biologics's estimated annual revenue is currently $9.5M per year.(i)
  • Stability Biologics's estimated revenue per employee is $251,000

Employee Data

  • Stability Biologics has 38 Employees.(i)
  • Stability Biologics grew their employee count by -12% last year.

Stability Biologics's People

NameTitleEmail/Phone
1
Associate VP, Marketing and Sales OperationsReveal Email/Phone
2
VPReveal Email/Phone
3
Area VP SalesReveal Email/Phone
4
SVP SalesReveal Email/Phone
5
VP, Finance & HRReveal Email/Phone
6
SVP SalesReveal Email/Phone
7
Regional Sales ManagerReveal Email/Phone
8
Senior Manager Customer ServiceReveal Email/Phone
9
Account ExecutiveReveal Email/Phone
10
Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12M480%N/AN/A
#2
$8.3M333%N/AN/A
#3
$1.8M7-22%N/AN/A
#4
$8M32-9%N/AN/A
#5
$34.9M139-20%N/AN/A
#6
$24.6M987%N/AN/A
#7
$30.4M1211%N/AN/A
#8
$15.1M609%N/AN/A
#9
$23.8M9512%N/AN/A
#10
$8.5M3431%N/AN/A
Add Company

What Is Stability Biologics?

Established in 2010, Stability Biologics quickly grew from a medical implant distributor to a national organization providing high quality allograft to leading physicians, hospitals and surgery centers throughout the United States. Stability's expertise in product design lead to the opening of their own tissue processing facility in 2014. Headquartered in Nashville, TN with its tissue processing and distribution center in San Antonio TX, Stability Biologics now provides a full line of human allograft available for distribution in the surgical fields of spine, orthopedics and wound care.

keywords:Biotechnology,Healthcare,Household & Personal Products,Medical Devices,Medical Diagnostics,Personal Products,Pharmaceuticals,Physical Security,Security

N/A

Total Funding

38

Number of Employees

$9.5M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Stability Biologics News

2022-04-20 - Dermatological Drugs Market to Record a YOY Growth Rate of ...

The dermatological drugs market share growth by the biologics ... The stability of most dermatological drugs also varies depending on...

2022-04-19 - WuXi Biologics Cayman : 2021 ESG Report

Lot Release/ Stability Testing. The strength of the WuXi Biologics' "Follow and Win the Molecule" business strategy continues to increase...

2022-04-19 - Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo

... of bio-innovative biologic medicines to improve patient access, ... so biologics are often formulated at high concentration to enable...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.2M3812%N/A
#2
$7.6M38-19%N/A
#3
$6.2M3812%N/A
#4
$3.5M38-10%N/A
#5
$5.5M3815%N/A